The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N07 | Other nervous system drugs | |
| 3 | N07B | Drugs used in addictive disorders | |
| 4 | N07BC | Drugs used in opioid dependence | |
| 5 | N07BC02 | Methadone |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 25 mg |
| PAREN - Parenteral | 25 mg |
| Active Ingredient | Description | |
|---|---|---|
| Methadone |
Methadone is a synthetic opioid analgesic similar to morphine although less sedative. It acts on the CNS system and smooth muscles via the peripheral nervous system. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| METHADOSE Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| MISYO Concentrate for oral solution | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| PHYSEPTONE MIXTURE Oral solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| PHYSEPTONE Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
